ATS 2023 Respiratory Innovation Summit

During the ATS 2023 Respiratory Innovation Summit, APIE Therapeutics presented a poster demonstrating preclinical efficacy of APT101 in a lung fibrosis model

APIE Therapeutics Welcomes Jim Greenwood to its Board of Directors

Cary, NC — APIE Therapeutics, a preclinical pharmaceutical company pioneering novel and proprietary drugs to activate the apelin receptor (APJ), announced the appointment of Jim Greenwood, former president & CEO of the Biotechnology Innovation Organization (BIO), to its board of directors. “Jim is known in the industry for his long tenure as president and CEO […]

IPF Summit 2022

During the IPF Summit, APIE Therapeutics presented a poster describing the novel apelin receptor agonist (APT101) and its effects in models of acute and chronic lung injury

APIE Therapeutics chosen as Start-Up Stadium Finalist

Start-Up Stadium was designed to provide start-up companies with the opportunity to access key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology event.  


The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors with strategic channel partners.

In 2022, RESI returns to JP Morgan in its successful virtual format, being held January 11-13, 2022. The week of JPM has been described as the World Series of early-stage life science and healthcare, bringing innovators, investors, and industry experts together to build relationships and make deals, which makes it a highly competitive event.